pioglitazone has been researched along with lobeglitazone in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bahia, MS; Chadha, N; Kaur, M; Silakari, O | 1 |
| Ahn, CW; Baik, SH; Cha, BS; Cho, YM; Jin, SM; Ku, BJ; Lee, KW; Lee, MK; Min, KW; Park, CY; Park, SW; Sung, YA; Yoon, KH | 1 |
| Im, YG; Im, YJ; Lee, MA; Tan, L; Yang, H | 1 |
| Gangopadhyay, KK; Singh, AK | 1 |
| Baik, M; Jeon, J; Kim, J; Yoo, J | 1 |
2 review(s) available for pioglitazone and lobeglitazone
| Article | Year |
|---|---|
Thiazolidine-2,4-dione derivatives: programmed chemical weapons for key protein targets of various pathological conditions.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Antidiuretic Agents; Antineoplastic Agents; Antioxidants; Drug Design; Humans; Molecular Targeted Therapy; Structure-Activity Relationship; Thiazolidinediones | 2015 |
Will lobeglitazone rival pioglitazone? A systematic review and critical appraisal.
Topics: Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Observational Studies as Topic; Pioglitazone; Sitagliptin Phosphate; Thiazolidinediones | 2023 |
1 trial(s) available for pioglitazone and lobeglitazone
| Article | Year |
|---|---|
Lobeglitazone and pioglitazone as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, parallel-group, active-controlled, phase III clinical trial with a 28-week extension.
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Fasting; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Male; Metformin; Middle Aged; Pioglitazone; Pyrimidines; Thiazolidinediones | 2015 |
2 other study(ies) available for pioglitazone and lobeglitazone
| Article | Year |
|---|---|
Structures of PPARĪ³ complexed with lobeglitazone and pioglitazone reveal key determinants for the recognition of antidiabetic drugs.
Topics: Binding Sites; Crystallography, X-Ray; Humans; Hypoglycemic Agents; Molecular Docking Simulation; Pioglitazone; PPAR gamma; Protein Structure, Tertiary; Pyrimidines; Recombinant Proteins; Thiazolidinediones | 2017 |
Lobeglitazone, a novel thiazolidinedione, for secondary prevention in patients with ischemic stroke: a nationwide nested case-control study.
Topics: Case-Control Studies; Diabetes Mellitus, Type 2; Heart Failure; Humans; Hypoglycemic Agents; Insulin Resistance; Ischemic Stroke; Logistic Models; Pioglitazone; Secondary Prevention; Stroke; Thiazolidinediones | 2023 |